Betamethasone Dipropionate Spray
Product Images NDC 51672-1390

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Betamethasone Dipropionate (NDC 51672-1390). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Betamethasone 01)

FDA Label Image

Figure A (Betamethasone 02)

FDA Label Image

Figure B (Betamethasone 03)

FDA Label Image

Figure C (Betamethasone 04)

FDA Label Image

Figure D (Betamethasone 05)

FDA Label Image

Principal Display Panel (60 mL Bottle Carton)

Principal Display Panel (60 mL Bottle Carton)
This is a medication with the active ingredient Betamethasone Dipropionate in the form of a spray for topical use. It should not be used orally, intravaginally or ophthalmically. The potency is expressed as Betamethasone. The product should be kept away from children and the pharmacist is advised to replace the cap with a spray pump. The usual dosage is to apply it on the affected area of the skin; for more information, consult with a healthcare professional. The product should be discarded 28 days after being dispensed by the pharmacy. The gram contains Betamethasone Propionate and several other ingredients. There is additional information about the manufacturer's location.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.